We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
+7.71%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$3.08B
AUM Growth
+$429M
(+16%)
Cap. Flow
+$303M
Cap. Flow
% of AUM
9.83%
Top 10 Holdings %
Top 10 Hldgs %
12.86%
Holding
1,336
New
161
Increased
732
Reduced
335
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$47.7M |
| 2 |
Visa
V
|
+$21.2M |
| 3 |
Chevron
CVX
|
+$16.5M |
| 4 |
PepsiCo
PEP
|
+$12.2M |
| 5 |
Abbott
ABT
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$17.1M |
| 2 |
AT&T
T
|
+$11.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$10.9M |
| 4 |
NVIDIA
NVDA
|
+$9.91M |
| 5 |
Parker-Hannifin
PH
|
+$9.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Healthcare | 14.19% |
| 3 | Consumer Discretionary | 11.25% |
| 4 | Industrials | 10.72% |
| 5 | Financials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
BlackSky Technology
BKSY
$1.17B
| $84K | ﹤0.01% |
6,997
+900
| +15% | +$12.1K |
|
1177
Coherus Oncology
CHRS
$192M
| $83.4K | ﹤0.01% |
+12,197
| New | +$94.7K |
|
1178
Caribou Biosciences
CRBU
$165M
| $83.2K | ﹤0.01% |
15,673
+192
| +1% | +$1.2K |
|
|
VRAY
1179
DELISTED
ViewRay, Inc.
VRAY
| $79.2K | ﹤0.01% |
22,879
+280
| +1% | +$1.19K |
|
|
LPRO
1180
DELISTED
Open Lending Corp
LPRO
| $78.6K | ﹤0.01% |
11,161
-164,084
| -94% | -$1.28M |
|
1181
Ultrapar
UGP
$6.42B
| $77.2K | ﹤0.01% |
28,280
+14,491
| +105% | +$36.6K |
|
|
LX
1182
LexinFintech Holdings
LX
$242M
| $77K | ﹤0.01% |
28,425
+3,003
| +12% | +$8.67K |
|
1183
TAL Education Group
TAL
$6.93B
| $77K | ﹤0.01% |
12,005
+502
| +4% | +$3.62K |
|
|
GRFS
1184
Grifois
GRFS
$5.48B
| $75.3K | ﹤0.01% |
+10,212
| New | +$88.6K |
|
1185
FIGS
FIGS
$2.39B
| $75.2K | ﹤0.01% |
12,146
-2,775
| -19% | -$21.4K |
|
1186
Pitney Bowes
PBI
$2.33B
| $74K | ﹤0.01% |
19,018
+5,233
| +38% | +$22K |
|
|
NBP
1187
NovaBridge Biosciences American Depositary Shares
NBP
$205M
| $72.1K | ﹤0.01% |
20,829
+8,500
| +69% | +$41.2K |
|
1188
Organogenesis Holdings
ORGO
$239M
| $71.8K | ﹤0.01% |
33,694
+14,476
| +75% | +$35.8K |
|
1189
Alector
ALEC
$189M
| $71.7K | ﹤0.01% |
11,582
+142
| +1% | +$1.16K |
|
|
ASTR
1190
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $71.1K | ﹤0.01% |
11,263
+1,736
| +18% | +$13.8K |
|
|
WTER
1191
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
| $70.9K | ﹤0.01% |
+29,556
| New | +$92.4K |
|
|
JMIA
1192
Jumia Technologies
JMIA
$743M
| $69.2K | ﹤0.01% |
21,033
+2,153
| +11% | +$7.75K |
|
1193
VTEX
VTEX
$687M
| $66.9K | ﹤0.01% |
17,428
-2,266
| -12% | -$9.23K |
|
1194
Gaotu Techedu
GOTU
$444M
| $65.9K | ﹤0.01% |
15,622
+2,735
| +21% | +$10.7K |
|
|
RERE
1195
ATRenew
RERE
$1.01B
| $63.9K | ﹤0.01% |
20,963
+1,779
| +9% | +$5.15K |
|
1196
RLX Technology
RLX
$2.44B
| $62.4K | ﹤0.01% |
+21,510
| New | +$52.1K |
|
1197
Telos
TLS
$302M
| $62.2K | ﹤0.01% |
24,600
| – | – |
|
|
SGMO
1198
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $58.9K | ﹤0.01% |
33,486
+1,243
| +4% | +$3.55K |
|
|
FINV
1199
FinVolution Group
FINV
$1.11B
| $55K | ﹤0.01% |
13,187
+1,440
| +12% | +$7.28K |
|
|
LIAN
1200
DELISTED
LianBio American Depositary Shares
LIAN
| $54.4K | ﹤0.01% |
27,778
-838
| -3% | -$1.74K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q1 2023 Portfolio in Review
As of Q1 2023, Vident Investment Advisory held 1,336 positions worth $3.08B, up 16% from $2.65B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Vident Investment Advisory deployed $303M of net new capital in Q1 2023, opening 161 new positions and adding to 732 existing holdings. Its largest new stake was Hormel Foods: 165,491 shares worth $6.6M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Philip Morris, an estimated $17.1M trimmed.
- Vident Investment Advisory's largest Q1 2023 buy was Hormel Foods: 165,491 shares worth $6.6M.
- Vident Investment Advisory added most to Apple in Q1 2023, an estimated $47.7M increase.
- Vident Investment Advisory's biggest Q1 2023 reduction was Philip Morris, cutting an estimated $17.1M.
- Vident Investment Advisory fully exited Coherent in Q1 2023, selling an estimated $5.89M.
- Vident Investment Advisory's ten largest holdings make up 13% of its $3.08B portfolio in Q1 2023.
- Vident Investment Advisory opened 161 new positions and closed 102 in Q1 2023.
- Vident Investment Advisory's portfolio value rose 16% quarter-over-quarter to $3.08B.
Based on Vident Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.